Gordon B A, Gordon K E, Hinton G G, Cadera W, Feleki V, Bayleran J, Hechtman P
Department of Biochemistry, University of Western Ontario, Canada.
Pediatr Neurol. 1988 Jan-Feb;4(1):54-7. doi: 10.1016/0887-8994(88)90026-4.
This first child of non-Jewish parents had nystagmus at 4 months of age, bilateral cherry-red macular spots at 7 months of age, and hyperacusis at 8 months of age; the patient has deteriorated progressively following a clinical course typical of Tay-Sachs disease B variant. Total beta-N-acetylhexosaminidase assayed with 4-methylumbelliferyl-beta-glucosamine (4 MU GlcNAc) as substrate was within the normal range in plasma and cultured dermal fibroblasts and 2/3 the normal mean in leukocytes. The hexosaminidase A activity, assayed with the same substrate in plasma and cultured fibroblasts, approximated Tay-Sachs disease heterozygote levels; however, the activity of hexosaminidase A assayed with 4 MU Glc NAc-6-sulfate in the plasma, leukocytes, and cultured fibroblasts was less than 8, 2, and 1%, respectively of the control mean. This female infant with the B1 variant of Tay-Sachs disease demonstrated an earlier onset and more rapidly progressive course than was observed in 4 of the 5 previously reported patients with this Tay-Sachs disease variant.
这个非犹太裔父母的头胎孩子在4个月大时出现眼球震颤,7个月大时出现双侧樱桃红斑,8个月大时出现听觉过敏;该患者遵循典型的B型泰-萨克斯病临床病程,病情逐渐恶化。以4-甲基伞形酮基-β-葡萄糖胺(4-MU GlcNAc)为底物检测的总β-N-乙酰己糖胺酶在血浆和培养的皮肤成纤维细胞中处于正常范围内,在白细胞中为正常平均值的2/3。用相同底物在血浆和培养的成纤维细胞中检测的己糖胺酶A活性接近泰-萨克斯病杂合子水平;然而,用4-MU Glc NAc-6-硫酸盐在血浆、白细胞和培养的成纤维细胞中检测的己糖胺酶A活性分别低于对照平均值的8%、2%和1%。这个患有B1型泰-萨克斯病的女婴比之前报道的5例该型泰-萨克斯病患者中的4例发病更早,病程进展更快。